Valneva SE SEC filings VALN
Valneva SE has 269 filings in SEC EDGAR's recent list, going back to Jan 15, 2021. Its latest annual report, Form 20-F, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 6, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 16, 2026 | — |
| CORRESP | Letter to the SEC | Jun 12, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2026 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2023 | — |
| EFFECT | Filing | Aug 19, 2022 | — |
| CORRESP | Letter to the SEC | Aug 17, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2022 | — |
| EFFECT | Filing | Oct 28, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2021 | — |
| DRS | Filing | Oct 20, 2021 | — |
| SEC STAFF LETTER | Filing | May 6, 2021 | — |
| CERT | Filing | May 6, 2021 | — |
| EFFECT | Filing | May 5, 2021 | — |
| EFFECT | Filing | May 5, 2021 | — |
| 8-A12B | Filing | May 3, 2021 | — |
| CORRESP | Letter to the SEC | May 3, 2021 | — |
| CORRESP | Letter to the SEC | May 3, 2021 | — |
| CORRESP | Letter to the SEC | Apr 21, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2021 | — |
| DRS/A | Filing | Mar 25, 2021 | — |
| DRS/A | Filing | Mar 24, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 16, 2021 | — |
| DRSLTR | Filing | Feb 24, 2021 | — |
| DRS/A | Filing | Feb 24, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2021 | — |
| DRS | Filing | Jan 15, 2021 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VALN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- France
- Headquarters
- Saint-Herblain, France
- SEC filer status
- Accelerated filer
- SEC CIK
- 1836564
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.